MediPal Holdings Corporation (MAHLY)

Market Cap	3.37B
Revenue (ttm)	24.52B
Net Income (ttm)	268.98M
Shares Out	n/a
EPS (ttm)	1.29
PE Ratio	12.53
Forward PE	n/a
Dividend	0.42 (2.35%)
Ex-Dividend Date	Mar 28, 2025

Volume	676
Average Volume	948
Open	17.50
Previous Close	14.95
Day's Range	17.50 - 18.00
52-Week Range	14.03 - 19.07
Beta	-0.01
RSI	30.91
Earnings Date	Jul 31, 2025

About MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for comp...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1898
• Employees: 13,075
• Stock Exchange: OTCMKTS
• Ticker Symbol: MAHLY

Financial Performance

In 2024, MediPal Holdings's revenue was 3.67 trillion, an increase of 3.16% compared to the previous year's 3.56 trillion. Earnings were 40.28 billion, a decrease of -2.88%.

Financial numbers in JPY